Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Targeted Drugs for Breast Cancer market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Targeted Drugs for Breast Cancermarket, defines the market attractiveness level of Targeted Drugs for Breast Cancer market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Targeted Drugs for Breast Cancer industry, describes the types of Targeted Drugs for Breast Cancer market, the applications of major players and the market size, and deeply analyzes the current situation of the global Targeted Drugs for Breast Cancer market and the development prospects and opportunities of Targeted Drugs for Breast Cancer industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Targeted Drugs for Breast Cancer market in Chapter 13.
By Player:
Pfizer
Allergan
Cipla
Bukwang Pharmaceutical Company
Hetero Drugs
Advenchen Laboratories
Reliance Life Science
Genentech
Mylan
Bayer
LSK BioPartners
Natco Pharma
Jiangsu Hengrui Medicine
Eli Lilly
By Type:
HER-2 Targeted Drugs
CDK4/6 Inhibitors
PARP Targeted Drugs
PI3K/AKT/mTor Pathway Inhibitors
ER Targeted Drugs
Aromatase Inhibitors
Tubulin Inhibitors
VEGF Targeted Drugs
YTMS Targeted Drugs
Other
By End-User:
Hospital
Clinic
Drug Center
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Targeted Drugs for Breast Cancer Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Targeted Drugs for Breast Cancer Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Targeted Drugs for Breast Cancer Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Targeted Drugs for Breast Cancer Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Targeted Drugs for Breast Cancer Market Analysis and Outlook to 2022
-
7.1 Global Targeted Drugs for Breast Cancer Consumption (2017-2022)
-
7.2 United States Targeted Drugs for Breast Cancer Consumption (2017-2022)
-
7.3 Europe Targeted Drugs for Breast Cancer Consumption (2017-2022)
-
7.4 China Targeted Drugs for Breast Cancer Consumption (2017-2022)
-
7.5 Japan Targeted Drugs for Breast Cancer Consumption (2017-2022)
-
7.6 India Targeted Drugs for Breast Cancer Consumption (2017-2022)
-
7.7 South Korea Targeted Drugs for Breast Cancer Consumption (2017-2022)
8 Region and Country-wise Targeted Drugs for Breast Cancer Market Analysis and Outlook to 2028
-
8.1 Global Targeted Drugs for Breast Cancer Consumption Forecast (2022-2028)
-
8.2 United States Targeted Drugs for Breast Cancer Consumption Forecast (2022-2028)
-
8.3 Europe Targeted Drugs for Breast Cancer Consumption Forecast (2022-2028)
-
8.4 China Targeted Drugs for Breast Cancer Consumption Forecast (2022-2028)
-
8.5 Japan Targeted Drugs for Breast Cancer Consumption Forecast (2022-2028)
-
8.6 India Targeted Drugs for Breast Cancer Consumption Forecast (2022-2028)
-
8.7 South Korea Targeted Drugs for Breast Cancer Consumption Forecast (2022-2028)
9 Global Targeted Drugs for Breast Cancer Market Outlook by Types and Applications to 2022
-
9.1 Global Targeted Drugs for Breast Cancer Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global HER-2 Targeted Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global CDK4/6 Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global PARP Targeted Drugs Consumption and Growth Rate (2017-2022)
-
9.1.4 Global PI3K/AKT/mTor Pathway Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.5 Global ER Targeted Drugs Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Aromatase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Tubulin Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.8 Global VEGF Targeted Drugs Consumption and Growth Rate (2017-2022)
-
9.1.9 Global YTMS Targeted Drugs Consumption and Growth Rate (2017-2022)
-
9.1.10 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Targeted Drugs for Breast Cancer Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drug Center Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Targeted Drugs for Breast Cancer Market Outlook by Types and Applications to 2028
-
10.1 Global Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global HER-2 Targeted Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global CDK4/6 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global PARP Targeted Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global PI3K/AKT/mTor Pathway Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global ER Targeted Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Aromatase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Tubulin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global VEGF Targeted Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.9 Global YTMS Targeted Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.10 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Drug Center Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Targeted Drugs for Breast Cancer Import and Export Analysis (Top 5 Countries)
-
11.1 Global Targeted Drugs for Breast Cancer Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Targeted Drugs for Breast Cancer Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Targeted Drugs for Breast Cancer Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Targeted Drugs for Breast Cancer Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Targeted Drugs for Breast Cancer Product and Service
-
14.2 Allergan
-
14.2.1 Allergan Company Details
-
14.2.2 Allergan Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Allergan Targeted Drugs for Breast Cancer Product and Service
-
14.3 Cipla
-
14.3.1 Cipla Company Details
-
14.3.2 Cipla Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Cipla Targeted Drugs for Breast Cancer Product and Service
-
14.4 Bukwang Pharmaceutical Company
-
14.4.1 Bukwang Pharmaceutical Company Company Details
-
14.4.2 Bukwang Pharmaceutical Company Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bukwang Pharmaceutical Company Targeted Drugs for Breast Cancer Product and Service
-
14.5 Hetero Drugs
-
14.5.1 Hetero Drugs Company Details
-
14.5.2 Hetero Drugs Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Hetero Drugs Targeted Drugs for Breast Cancer Product and Service
-
14.6 Advenchen Laboratories
-
14.6.1 Advenchen Laboratories Company Details
-
14.6.2 Advenchen Laboratories Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Advenchen Laboratories Targeted Drugs for Breast Cancer Product and Service
-
14.7 Reliance Life Science
-
14.7.1 Reliance Life Science Company Details
-
14.7.2 Reliance Life Science Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Reliance Life Science Targeted Drugs for Breast Cancer Product and Service
-
14.8 Genentech
-
14.8.1 Genentech Company Details
-
14.8.2 Genentech Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Genentech Targeted Drugs for Breast Cancer Product and Service
-
14.9 Mylan
-
14.9.1 Mylan Company Details
-
14.9.2 Mylan Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Mylan Targeted Drugs for Breast Cancer Product and Service
-
14.10 Bayer
-
14.10.1 Bayer Company Details
-
14.10.2 Bayer Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bayer Targeted Drugs for Breast Cancer Product and Service
-
14.11 LSK BioPartners
-
14.11.1 LSK BioPartners Company Details
-
14.11.2 LSK BioPartners Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 LSK BioPartners Targeted Drugs for Breast Cancer Product and Service
-
14.12 Natco Pharma
-
14.12.1 Natco Pharma Company Details
-
14.12.2 Natco Pharma Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Natco Pharma Targeted Drugs for Breast Cancer Product and Service
-
14.13 Jiangsu Hengrui Medicine
-
14.13.1 Jiangsu Hengrui Medicine Company Details
-
14.13.2 Jiangsu Hengrui Medicine Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Jiangsu Hengrui Medicine Targeted Drugs for Breast Cancer Product and Service
-
14.14 Eli Lilly
-
14.14.1 Eli Lilly Company Details
-
14.14.2 Eli Lilly Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Eli Lilly Targeted Drugs for Breast Cancer Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Targeted Drugs for Breast Cancer
-
Figure Targeted Drugs for Breast Cancer Picture
-
Table Global Targeted Drugs for Breast Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Targeted Drugs for Breast Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Targeted Drugs for Breast Cancer Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Targeted Drugs for Breast Cancer Consumption by Country (2017-2022)
-
Figure United States Targeted Drugs for Breast Cancer Consumption and Growth Rate (2017-2022)
-
Table Europe Targeted Drugs for Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure China Targeted Drugs for Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Japan Targeted Drugs for Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure India Targeted Drugs for Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure South Korea Targeted Drugs for Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Drugs for Breast Cancer Consumption Forecast by Country (2022-2028)
-
Figure United States Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Targeted Drugs for Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HER-2 Targeted Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global CDK4/6 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global PARP Targeted Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global PI3K/AKT/mTor Pathway Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global ER Targeted Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Aromatase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Tubulin Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global VEGF Targeted Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global YTMS Targeted Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Center Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global HER-2 Targeted Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CDK4/6 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PARP Targeted Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PI3K/AKT/mTor Pathway Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ER Targeted Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aromatase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tubulin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global VEGF Targeted Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global YTMS Targeted Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Targeted Drugs for Breast Cancer Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Targeted Drugs for Breast Cancer Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Targeted Drugs for Breast Cancer Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Targeted Drugs for Breast Cancer Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Targeted Drugs for Breast Cancer Product and Service
-
Table Bukwang Pharmaceutical Company (Foundation Year, Company Profile and etc.)
-
Table Bukwang Pharmaceutical Company Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bukwang Pharmaceutical Company Targeted Drugs for Breast Cancer Product and Service
-
Table Hetero Drugs (Foundation Year, Company Profile and etc.)
-
Table Hetero Drugs Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hetero Drugs Targeted Drugs for Breast Cancer Product and Service
-
Table Advenchen Laboratories (Foundation Year, Company Profile and etc.)
-
Table Advenchen Laboratories Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advenchen Laboratories Targeted Drugs for Breast Cancer Product and Service
-
Table Reliance Life Science (Foundation Year, Company Profile and etc.)
-
Table Reliance Life Science Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Reliance Life Science Targeted Drugs for Breast Cancer Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Targeted Drugs for Breast Cancer Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Targeted Drugs for Breast Cancer Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Targeted Drugs for Breast Cancer Product and Service
-
Table LSK BioPartners (Foundation Year, Company Profile and etc.)
-
Table LSK BioPartners Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table LSK BioPartners Targeted Drugs for Breast Cancer Product and Service
-
Table Natco Pharma (Foundation Year, Company Profile and etc.)
-
Table Natco Pharma Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Natco Pharma Targeted Drugs for Breast Cancer Product and Service
-
Table Jiangsu Hengrui Medicine (Foundation Year, Company Profile and etc.)
-
Table Jiangsu Hengrui Medicine Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiangsu Hengrui Medicine Targeted Drugs for Breast Cancer Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Targeted Drugs for Breast Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Targeted Drugs for Breast Cancer Product and Service
-
